预防性介入在肝癌术后治疗中的价值  

Clinic effect of prophylactic interventional therapy in treatment of hepatocellular carcinoma after hepatectomy

作　　者：罗荣光[1] 田秋红[2] 钟久鸿[2] 张战民[2] 曾兵文 

机构地区：[1]南昌大学第一附属医院影像科,南昌330006 [2]南昌大学第一附属医院肿瘤科,南昌330006 [3]江西省永新县人民医院放射科,永新343400

出　　处：《江西医药》2015年第11期1137-1139,共3页Jiangxi Medical Journal

基　　金：江西省卫生厅课题科技计划项目(20133040)

摘　　要：目的评价预防性介入在肝癌患者术后治疗中的价值。方法收集2010年我院肝癌术后患者73例进行回顾性分析。A组32例患者于肝癌术后行预防性介入治疗,B组41例患者未行预防性介入治疗。比较A、B两组患者1、2、3、4年复发率及生存率的差异。结果两组患者1、2、3、4复发率的差异无统计学意义;两组患者1、2,3年生存率差异有统计学意义,两组患者4年生存率差异无统计学意义。结论预防性介入并未降低肝癌患者术后复发率,但可能提高1-3年近期生存率。Objective To evaluate prophylactic interventional therapy in treatment of hepatocellular carcinoma（HCC） after hepatectomy. Methods A retrospective analysis of 73 cases of HCC patients in our hospital were collected in this study in 2010.In group A,32 patients were treated with prophylactic interventional therapy after HCC resection,and 41 patients in group B were treated without prophylactic interventional therapy. The difference of 1-,2-,3-,4-year recurrence rate and survival rate were compared between this two groups. Results There were no significant differences in recurrence rate within 1-,2-,3-,4-year between group A and B. The survival rate differences within 1-,2-,3-year between group A and B were statistically significant. But the differences of 4-year survival rate of this two groups were no statistically significant. Conclusion The prophylactic interventional therapy did not decrease the recurrence rate,but it maybe increase 1-,2-,3-year survival rate.

关 键 词：TACE 肝肿瘤 介入放射学 

分 类 号：R735.7[医药卫生—肿瘤]